The Complementary Plan for Biotechnology applied to Health launches the call for applications for grants for Collaborative Projects in Catalonia

Type of projects: 

Two modalities will be funded; projects between 2 entities (A) and projects between 3 or more entities (B). Minimum participation: one basic research institution and one health research institution (both Catalan), and collaboration from another autonomous community participating in the Complementary Biotechnology Plan. 


Catalan, public or private, not-for-profit entities with demonstrated capacity and competence to carry out scientific and technical research activities focused on personalized medicine. 


The maximum total amount of the grants is 3,573,000 €, intended to finance personnel costs and other expenses related to the objectives of the project. This amount is funded by the Recovery and Resilience Mechanism of the European Union and the Autonomous Community of Catalonia. 


The grants will be awarded as a subsidy, under the modality of competitive concurrence. 

Deadline for submission of applications: 

From July 1st, 2022 to September 15th, 2022 at 17:00 hours (Spanish peninsular time). 

Bases of the call for Collaborative Plans in Catalonia: 

Bases of the call  

More information about Complementary Plans in Biotechnology applied to Health 


The Complementary Plan in Biotechnology applied to Health is co-financed by the Ministry of Science and Innovation with funds from the European Union NextGenerationEU (PRTR-C17.I1). 

It is co-governed and co-financed by the Administrations of the Autonomous Communities of the Basque Country, Catalonia, Galicia, Castile-La Mancha, Extremadura, Andalucia and Aragón and seeks to develop tools for diagnosis, prognosis and advanced therapies in personalized medicine, with the aim of addressing health challenges such as cancer, diseases associated with aging, infectious diseases and minority diseases. 

With a budget of 37 million Euros, and coordinated by the Institute for Bioengineering of Catalonia (IBEC), this Complementary Plan represents the largest interregional collaboration in personalized medicine. In addition, this biotechnology health research consortium is one of the largest in the history of Spain, and one of the best funded.